急性冠状动脉综合征患者强化他汀治疗专家共识

被引：94

作者：

霍勇 ^{[1
]}

葛均波 ^{[2
]}

韩雅玲 ^{[3
]}

王建安 ^{[4
]}

万征 ^{[5
]}

李建平 ^{[1
]}

钱菊英 ^{[2
]}

王斌 ^{[3
]}

项美香 ^{[4
]}

孙跃民 ^{[5
]}

代表急性冠状动脉综合征患者强化他汀治疗专家共识专家组

机构：

[1] 北京大学第一医院

[2] 复旦大学附属中山医院

[3] 沈阳军区总医院

[4] 浙江大学医学院附属第二医院

[5] 天津医科大学总医院

来源：

中国介入心脏病学杂志 | 2014年 / 22卷 / 01期

关键词：

急性冠状动脉综合征; 强化他汀治疗; 专家共识;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

1002 ; 100201 ;

摘要：

<正>一、制定共识的必要性1.急性冠状动脉综合征和他汀类药物:急性冠状动脉综合征(acute coronary syndrome,ACS)是一组以急性心肌缺血为共同特征的临床综合征,包括不稳定型心绞痛(UA)、非ST段抬高心肌梗死(NSTEMI)和ST段抬高心肌梗死(STEMI)[1]。ACS主要发生机制为易损斑块破裂或溃疡合并血栓形成和(或)血管痉挛,引起冠状动脉狭窄程度急剧加重或急性闭塞[2]。ACS的罪犯病变通常

引用

页码：4 / 6

页数：3

共 21 条

[1] 早期阿托伐他汀强化治疗对急性冠脉综合征患者PCI术后预后的影响 [J].

李京倡 ;

张晓 .

中国现代医学杂志, 2012, (31) :61-64

[2]

中国成人血脂异常防治指南[J]. 中华心血管病杂志. 2007(05)

[3]

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update[J] . Michael V. Rocco.American Journal of Kidney Diseases . 2012 (5)

[4] Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury [J].

Yu, Xing Long ;

Zhang, Hai Juan ;

Ren, Shao Da ;

Geng, Jing ;

Wu, Ting Ting ;

Chen, Wen Qiang ;

Ji, Xiao Ping ;

Zhong, Lin ;

Ge, Zhi Ming .

CORONARY ARTERY DISEASE, 2011, 22 (02) :87-91

[5]

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials[J] . Naveed Sattar,David Preiss,Heather M Murray,Paul Welsh,Brendan M Buckley,Anton JM de Craen,Sreenivasa Rao Kondapally Seshasai,John J McMurray,Dilys J Freeman,J Wouter Jukema,Peter W Macfarlane,Chris J Packard,David J Stott,Rudi G Westendorp,James Shepherd,Barry R Davis,Sara L Pressel,Roberto Marchioli,Rosa Maria Marfisi,Aldo P Maggioni,Luigi Tavazzi,Gianni Tognoni,John Kjekshus,Terje R Pedersen,

[6]

Evidence of Pre-Procedural Statin Therapy[J] . David E. Winchester,Xuerong Wen,Lola Xie,Anthony A. Bavry.Journal of the American College of Cardiology . 2010 (14)

[7]

Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathways for Acute Coronary Syndromes in China （CPACS） study[J] . Yufang Bi,Runlin Gao,Anushka Patel,Steve Su,Wei Gao,Dayi Hu,Dejia Huang,Lingzhi Kong,Wenhang Qi,Yangfeng Wu,Yuejin Yang,Fiona Turnbull.American Heart Journal . 2009 (3)

[8]

Novel Approaches for Preventing or Limiting Events （Naples） II Trial[J] . Carlo Briguori,Gabriella Visconti,Amelia Focaccio,Bruno Golia,Alaide Chieffo,Alfredo Castelli,Marco Mussardo,Matteo Montorfano,Bruno Ricciardelli,Antonio Colombo.Journal of the American College of Cardiology . 2009 (23)

[9]

Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention[J] . Germano Di Sciascio,Giuseppe Patti,Vincenzo Pasceri,Achille Gaspardone,Giuseppe Colonna,Antonio Montinaro.Journal of the American College of Cardiology . 2009 (6)

[10] Comparison of Effectiveness of Atorvastatin 10 mg Versus 80 mg in Reducing Major Cardiovascular Events and Repeat Revascularization in Patients With Previous Percutaneous Coronary Intervention (Post Hoc Analysis of the Treating to New Targets [TNT] Study) [J].

Johnson, Colleen ;

Waters, David D. ;

DeMicco, David A. ;

Breazna, Andrei ;

Bittner, Vera ;

Greten, Heiner ;

Grundy, Scott M. ;

LaRosa, John C. .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (10) :1312-1317

← 1 2 3 →